Accessibility links Skip to main content

GAMP® 5: Insights from the Update to the 2nd Edition

After 14 years, ISPE published the second edition of the GAMP® 5 guide, “A Risk-Based Approach to Compliant GxP Automated Systems,” in August 2022. Although the core principles of the first edition remain relevant, several new topics have been added to provide guidance on how certain technological innovations can be used optimally and correctly within a GxP environment. At the same time, existing topics have been further clarified.

Contact us

Fill out the form and we will contact you shortly.

Naam
Privacy Policy 
Continue reading

The principles described in the 2nd edition of GAMP® 5 provide advanced guidelines for achieving GxP-compliant automated systems that are fit for their intended use and meet regulatory requirements. By correctly applying the knowledge from the GAMP guide, you ensure that compliance is achieved in a way that adds value to your business. This is done by focusing on aspects that are critical to patient safety, product quality, and data integrity.

The approach is not only aimed at achieving compliance but also at maintaining it throughout the system’s lifecycle. One of the updates concerns how to scale or define the validation approach: It must be ensured that this is based on a thorough understanding of the business process and the system or product. To do this effectively, historical data and supplier knowledge must not be overlooked. The validation effort must be proportionate to the level of risk, the scope and complexity of the system, the novelty, and the outcome of the supplier assessment, with an emphasis on the elements that most significantly impact patient safety, product quality, and data integrity.

Although the first edition already stated that the validation approach must be scaled and justified, the second edition gives this the attention it deserves through the concept of critical thinking, as this is what defines sound and intelligent validation. Critical thinking must be applied so that decisions are made in a well-informed and rational manner at crucial moments within the system’s lifecycle. This certainly does not mean that all systems must be treated the same way, nor that the same lifecycle activities must be applied to a system when it is used in different organizations or for different intended applications.

Software development has evolved over the years. Large projects are increasingly carried out in a non-linear manner, as this is the best approach for discovery, learning, and continuous improvement. The 2nd edition describes how specification and verification can be efficiently addressed when using more iterative and incremental methods, such as Agile software development for applications intended for use in a GxP environment. Nevertheless, the linear approach remains suitable for projects in which requirements are fully identified and defined from the outset (for example, smaller software development projects or the procurement of COTS products).

Due to the increasing use of cloud services (IaaS, PaaS, and SaaS)—that is, the outsourcing of infrastructure, the software platform, or the software application—the importance of service providers has grown, a topic addressed in the update. The use of supplier knowledge, experience, and documentation must, where possible, be done in a justified manner.

The approach to software development and validation must be adapted to the assessment of the supplier and the amount of usable results. In addition to the increasingly iterative and incremental nature of software development, the use of software tools and automation has also increased, as their use can facilitate greater control and lower risk levels throughout the lifecycle, thereby delivering a higher-quality product. Tools and systems can be used at various stages, namely during implementation (specifying requirements, conducting risk assessments, etc.), testing, and maintenance of automated systems. The focus should be on testing that adds value, while cumbersome documentation should be avoided.

Various types of testing can be used to optimally verify the system for its intended use. By using systems, it is also no longer necessary to record all information about the system in a traditional paper-based manner; instead, information can be recorded in systems and tools as appropriate, which increases efficiency and reduces the manual workload during the various lifecycle phases while ensuring improved traceability, searchability, and data security. To overcome the inherent reluctance of GxP sectors to implement new emerging technologies without guidance, the 2nd edition specifically addresses several new technologies that can offer new benefits if embraced. Guidance and examples are provided on the use of blockchain, artificial intelligence, and machine learning within GxP applications. Another part of the update concerns improved alignment with the IT Infrastructure Library (ITIL), which provides IT guidelines for best practices in managing IT services and improving IT support and service levels.

Looking for validation services?

FC&P offers validation services that comply with the latest regulations and guidelines, such as GAMP 2nd Edition regarding the validation of automated systems. For assistance in defining validation approaches, implementing identified lifecycle outcomes, and other validation and quality services, please contact us.

About the author:

Tom Van Gompel is Lead Validation at FC&P. He has experience in various validation activities, particularly equipment validation, process validation, and the validation of automated systems. He also has a strong background in QA and QC activities and can support you in the development, optimization, and digitization of your quality processes.

Your partner in quality, safety, and compliance

The life sciences sector requires specialized knowledge and reliable guidance. Thanks to our extensive expertise, we help organizations comply with laws and regulations, ensure quality, and continue to innovate with confidence.

Related services

Medical Team Performing Surgical Operation in Bright Modern Operating Room

Quality Management System (QMS)

Program and Project Management

Related Articles

10 Jul 2026

Project Management

In the complex and highly regulated world of the pharmaceutical industry, project management plays a pivotal role to bring life-saving medications and treatments to the market. From drug discovery to clinical trials and regulatory approval, effective project management is essential for managing timelines, resources, and compliance. Let’s dive in some practical tips and tricks specifically for navigating the complexities of project management in the pharmaceutical sector.

10 Jul 2026

Potential Pitfalls in an MES Project

Just as every project has its pitfalls, the same is true for a Manufacturing Execution System (MES) implementation project. Implementing electronic batch records is no easy task. That’s why, in the blog below, we’ll share a few pitfalls so you can prepare for a successful implementation within your company.

10 Jul 2026

Streamlining Post-Marketing Surveillance with IMDRF Coding

Since the implementation of the Medical Device Regulation (MDR) in Europe, companies have had to maintain and execute a post-marketing surveillance (PMS) procedure. This systematic process involves collecting and analysing data on the performance and safety of medical devices after they have been released to the market. The primary goal is to help manufacturers identify and address potential issues that may arise during actual use, monitor the market for known risks, and identify new risks.

10 Jul 2026

ISO 9001:2015 in Life Sciences Industry

In the life sciences industry, maintaining high quality standards is critical not only to the success and sustainability of organizations but also to patient safety and compliance. ISO 9001:2015, part of the ISO 9000 family, provides a robust framework for quality management systems (QMS) that can be used in organizations in the life sciences, including pharmaceutical, natural technology, including medical devices. This article examines the key features of ISO 9001:2015, its benefits, implementation methods, potential pitfalls, and impact in the life sciences.

10 Jul 2026

The Role of a CQV Expert in the Cold Chain Division of a Pharmaceutical Company

In the pharmaceutical industry, product quality is of vital importance. This is particularly true for medicinal products that are sensitive to temperature fluctuations, such as vaccines, biologics, and certain medications that must be stored and transported in a controlled environment. Within this process, the CQV (Commissioning, Qualification, and Validation) expert plays a crucial role, especially within the cold chain division, which is responsible for monitoring product quality during the transport and storage of these temperature-sensitive products. This blog outlines the various aspects a CQV expert must consider in this context.

10 Jul 2026

Radiopharmaceutical & Selective Internal Radiation Treatments: Overcoming Challenges and Embracing Future Opportunities

Radiopharmaceutical and selective internal radiation treatments have emerged as a transformative force in the pharmaceutical industry, offering precision, personalized therapies for patients with conditions such as cancer and other serious diseases.

10 Jul 2026

Implementation of the European Clinical Trial Regulation (EU-CTR)

By the end of this month (31st of January 2025), the final deadline is reached in the transition period for the implementation of the European Clinical Trial Regulation (EU-CTR). What is it and what is the difference with the previous European Clinical Trial Directive (EU-CTD)?